Centiva Capital’s Zai Lab ZLAB Stock Holding History

Centiva Capital’s Portfolio ZLAB Stock Details ZLAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-1,182	Closed	-$209K	–	1657
2021 Q2	$209K	Buy	+1,182	New	+$190K	﹤0.01%	1205

Other funds holding ZLAB

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

BAM

Brilliance Asset Management Admiralty, Hong Kong, Hong Kong $339M AUM 8.73% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Centiva Capital's ZLAB Position: Q3 2021 in Review

Centiva Capital sold out of Zai Lab (ZLAB) in Q3 2021, closing a stake of 1,182 shares — an estimated $209K sold.

Centiva Capital first reported a position in ZLAB in Q2 2021 and held it in 1 quarter. The position peaked at $209K in Q2 2021. 228 funds tracked by Wall St. Rank hold ZLAB as of Q3 2021.

Centiva Capital reported no remaining Zai Lab position as of Q3 2021 after selling out during the quarter.
Centiva Capital sold 1,182 Zai Lab shares in Q3 2021, an estimated $209K.
Centiva Capital first reported a position in Zai Lab in Q2 2021 and held it in 1 quarter.
Centiva Capital's Zai Lab position peaked at $209K in Q2 2021.
228 funds tracked by Wall St. Rank held Zai Lab as of Q3 2021.

Based on Centiva Capital's 13F filing for Q3 2021, filed 15 Nov 2021.